Summary
The rule amendment to 64B13-3.002, F.A.C. will delete language that is a restatement of section 456.057(2), F.S., and renumber the rule accordingly; the proposed amendment to 64B13-3.006, F.A.C. will delete language that is a restatement of subsection 463.011, F.S. from the rule and renumber the rule accordingly; the proposed amendment to 64B13-3.008, F.A.C., will delete language from the rule that is a restatement of subsections 463.001, 463.002, and 463.014, F.S., and renumber the rule accordingly; The proposed amendment to 64B13-3.009 will delete language that is a policy statement and does not constitute a rule, restates subsection 463.016, F.S., and delete language that contradicts Florida Statutes and renumber the rule accordingly; the proposed amendment to 64B13-3.010 will delete language that restates subsections 463.016, 463.0135, and 463.072, F.S., add language to clarify administration and prescription of ocular pharmaceutical agents, and renumber the rule accordingly; the proposed amendment to 64B13-3.012 will delete unnecessary language from the rule and renumber the rule accordingly; the proposed amendment to 64B13-3.015 will delete language from the rule that is a restatement of section 463.009, F.S. and renumber the rule accordingly.